Skip to content
Back to Investors
Ascension

Ascension

Venture Capital

Ascension Ventures is a venture capital firm that led the pre-seed funding round for Voxmind.


Recent investments

Pre-Seed
£800K

Ascension's Fair By Design fund led the pre-seed round, with participation from Ada Ventures, Redrice Ventures and True.

"While dialogue around an ageing population focuses on the growing burden on health services, my experience sees a generation of people with more energy, desire for life and time than ever before,"
— Alex Ramamurthy, Co-Founder
Seed
£1.1M

The early seed round was led by Fair By Design with participation from GC Angels and Ascension Ventures.

"On top of the obvious grief and shock, I discovered that the end-of-life industry was expensive and difficult to navigate, especially in an intensely emotional time. The industry had been largely untouched by technological innovation and needed to rapidly modernise."
— Sam Grice, Founder
Seed
£2.5M

The financing round was backed by investors including Ascension and Connect Ventures.

"Just four weeks into launching and we’re delighted to have a number of notable investors on board who really believe in our vision and back this app. We’ve got big plans with a clear mission, to change a culture of how people date. This is just the start and we will deliver. Dating apps just got exciting again."
— George Rawlings, Co-founder
Seed
£2.0M

The financing round was led by IQ Capital with participation from Hambro Perks and Ascension Ventures.

"This latest round of investment is a great recognition of our customers' success through our breakthrough AI and a product focused approach. With our existing investors reaffirming their support of the company and new investors with vast experience in the life sciences industry coming on board, we are on course to achieve our core mission of improving patient outcomes through a highly profitable and sustainable business model. In the past 12 months, the company has grown 15 times through the successful deployment of PIE in the biopharmaceutical industry, partnerships with healthcare data providers and significant contributions to peer review publications, which demonstrates that we are leading in this sector. This funding will accelerate this success by providing the resources to strengthen the team, explore new use cases, and expand into new markets."
— Vibhor Gupta, CEO
Pre-Seed
£380K

RLC Ventures led the pre-seed round with backing from Ascension Ventures and Force Over Mass Capital to fund product development and market expansion.

"We are delighted to have such award-winning investors supporting us and sharing in our vision. We look forward to showing treasurers how revolutionary modern technology can reduce technical complexity and improve the analytical capabilities of their teams."
— Kelly Scammell, CEO